The Enterprise Value as of December 2024 (TTM) for Aeterna Zentaris Inc. (AEZS) is -11767918.00

According to Aeterna Zentaris Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is -11767918.00. This represents a change of 671.54% compared to the average of -1525245.66 of the last 4 quarters.

Aeterna Zentaris Inc. (AEZS) Historical Enterprise Value (quarterly & annually)

How has AEZS Enterprise Value performed in the past?

The mean historical Enterprise Value of Aeterna Zentaris Inc. over the last ten years is 77.01M. The current -11767918.00 Enterprise Value has changed -1628.13% with respect to the historical average. Over the past ten years (40 quarters), AEZS's Enterprise Value was at its highest in in the March 2021 quarter at 362.00M. The Enterprise Value was at its lowest in in the March 2024 quarter at -26743591.88.

Aeterna Zentaris Inc. (AEZS) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Aeterna Zentaris Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Aeterna Zentaris Inc. (AEZS) Average Enterprise Value

How has AEZS Enterprise Value performed in the past?

The current Enterprise Value of Aeterna Zentaris Inc. (AEZS) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Aeterna Zentaris Inc. (AEZS) Enterprise Value vs. Peers

How is AEZS’s Enterprise Value compared to its peers?

Aeterna Zentaris Inc.’s Enterprise Value is less than Pulmatrix, Inc. (10.26M), less than Onconova Therapeutics, Inc. (32.62M), less than Catalyst Biosciences, Inc. (1.03B), less than Bio-Path Holdings, Inc. (4.24M), less than Moleculin Biotech, Inc. (-3378743.00), less than Adial Pharmaceuticals, Inc. (1.39M), less than Diffusion Pharmaceuticals Inc. (10.50M), less than Tonix Pharmaceuticals Holding Corp. (52.98M), less than Jaguar Health, Inc. (0), less than Acasti Pharma Inc. (32.52M), less than iBio, Inc. (14.78M), less than TransCode Therapeutics, Inc. (14.79M), less than Aditxt, Inc. (769.13K), less than Reviva Pharmaceuticals Holdings, Inc. (12.44M), less than Avenue Therapeutics, Inc. (70.91M), less than null (1.10M),

Build a custom stock screener for Aeterna Zentaris Inc. (AEZS) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Aeterna Zentaris Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Aeterna Zentaris Inc. (AEZS) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Aeterna Zentaris Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.